The World Health Organization (WHO) Global TB Program is launching a second call for case studies of programmatic innovations to maintain and improve TB prevention and care in the context of the COVID-19 pandemic.

The Stop TB Partnership welcomed the new leadership of the Stop TB Partnership Board, India’s Minister of Health and Family Welfare, Mr. Mansukh Mandaviya, as the new Chair of the Stop TB Partnership Board with immediate effect and until 2024. The Minister will lead the efforts of the Stop TB Partnership Secretariat, partners, and the TB community at large, towards reaching the UN TB targets by 2022, a milestone moment in the effort to end TB by 2030.

26 August 2021 | Geneva - A rapid communication released by the World Health Organization (WHO) Global Tuberculosis Programme has announced important updates to guidance on the management of tuberculosis (TB) in children and adolescents. This includes new recommendations on diagnostic options, treatment regimens, as well as treatment decision algorithms and optimal models of care for the delivery of child and adolescent TB services.

RESIST-TB released its August 2021 newsletter with the latest research publications on drug-resistant TB.

24 August 2021, Geneva, Switzerland – Lancet Digital Health just published the new ground-breaking study by the Stop TB Partnership, showing that artificial intelligence (AI) by far outperformed experienced human radiologists in diagnosing tuberculosis (TB).

WEST LAFAYETTE, Ind. and HOUSTON, August 20, 2021 – Innovators at Purdue University and Houston Methodist Research Institute have created a novel strategy for developing an effective vaccine for a widespread form of tuberculosis.

On 12 August 2021, TB Alliance hosted a public webinar for community stakeholders to share details of the recently announced results from the ZeNix Phase 3 clinical trial. The trial revealed that the 6-month BPaL treatment regimen (bedaquiline, pretomanid and linezolid) remains effective against highly drug-resistant strains of TB with either reduced dosage or duration of the linezolid component of the regimen. Simultaneously, with the maintenance of efficacy, there was a decrease in linezolid associated side effects.

August 16, 2021: Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy (TPT).

The TB Europe Coalition developed a booklet 'Multisectoral accountability framework to accelerate progress to end TB (MAF-TB). The political will at the national level is the key to fulfilling the global commitments' to support civil society and TB affected communities in understanding the global policy background, objectives, and milestones of the implementation of MAF-TB.

The Stop TB Partnership applauds the Presidential TB Bill that crowns Indonesia’s commitment to ending the TB epidemic by 2030.